Overview
Lifeway Q3 2025 net sales of $57.1 mln beat analyst expectations
Net income for Q3 2025 grew 19%, reflecting disciplined operational execution
Gross margin expanded by 300 basis points year-over-year in Q3 2025
Outlook
Company targets $45–$50 mln in Adjusted EBITDA for FY 2027
Lifeway expects record annual sales in FY 2025
Company investing in marketing and manufacturing to support growth
Result Drivers
FLAGSHIP PRODUCT DEMAND - Lifeway Kefir and Farmer Cheese drove record net sales, highlighting strong consumer demand
PLANT EXPANSION - Completion of Waukesha plant expansion increased capacity and operational efficiency
NEW PRODUCT INNOVATION - Introduction of Muscle Mates and partnerships with health-focused brands to meet consumer demand
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Beat
$57.14 mln
$55 mln (1 Analyst)
Q3 Net Income
$3.53 mln
Q3 Gross Profit
$16.41 mln
Q3 Income From Operations
$5.04 mln
Q3 Operating Expenses
$11.37 mln
Analyst Coverage
The one available analyst rating on the shares is "buy"
Wall Street's median 12-month price target for Lifeway Foods Inc is $33.00, about 29.3% above its November 11 closing price of $23.33
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 25 three months ago
Press Release: ID:nPn5hntba
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)